esophageal carcinoma
Showing 26 - 43 of 43
Esophageal Carcinoma Trial in Amsterdam (Pertuzumab, trastuzumab)
Completed
- Esophageal Carcinoma
- Pertuzumab, trastuzumab
-
Amsterdam, NetherlandsAcademic Medical Center, Medical Oncology
Jun 29, 2020
Esophageal Carcinoma, Esophageal Cancer Trial in Utrecht (Esophagectomy)
Completed
- Esophageal Carcinoma
- Esophageal Cancer
- Esophagectomy
-
Utrecht, NetherlandsUMC Utrecht
Mar 25, 2020
Esophageal Cancer, Esophageal Carcinoma Trial in Nanjing, Nanchang, Shanghai (esophagectomy)
Recruiting
- Esophageal Cancer
- Esophageal Carcinoma
- esophagectomy
-
Nanjing, Jiangsu, China
- +5 more
Feb 3, 2020
Esophageal Carcinoma Trial in Beijing (concurrent chemoradiotherapy plus DC-CIK immunotherapy, Concurrent chemoradiation only)
Unknown status
- Esophageal Carcinoma
- concurrent chemoradiotherapy plus DC-CIK immunotherapy
- Concurrent chemoradiation only
-
Beijing, Beijing, ChinaCapital Medical University Cancer Center
Jan 2, 2020
Esophageal Carcinoma Trial in Beijing (SHR-1210, Docetaxel, Irinotecan)
Completed
- Esophageal Carcinoma
- SHR-1210
- +2 more
-
Beijing, China
- +1 more
Oct 23, 2019
Esophageal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Rochester, Omaha, Green Bay (Doxepin Hydrochloride,
Terminated
- Esophageal Carcinoma
- +13 more
- Doxepin Hydrochloride
- +3 more
-
Rochester, Minnesota
- +2 more
Sep 10, 2019
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Carcinoma Trial in Beijing (Icotinib)
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- Esophageal Carcinoma
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jul 2, 2019
Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer Trial in New York (Narrow Band Imaging (NBI))
Completed
- Endometrial Cancer
- +7 more
- Narrow Band Imaging (NBI)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 6, 2018
Barrett Esophagus, Esophageal Carcinoma Trial in Tucson, Chapel Hill (Ursodiol, Laboratory Biomarker Analysis)
Completed
- Barrett Esophagus
- Esophageal Carcinoma
- Ursodiol
- Laboratory Biomarker Analysis
-
Tucson, Arizona
- +3 more
Nov 22, 2017
Colon Cancer, Esophageal Carcinoma, Pancreatic Cancer Trial in Chendu (CAR-T cell immunotherapy)
Unknown status
- Colon Cancer
- +5 more
- CAR-T cell immunotherapy
-
Chendu, ChinaIEC of Chengdu Medical College
Jan 4, 2017
Esophageal Carcinoma Trial in Ann Arbor (Tetrathiomolybdate (TM), Radiation, Surgery)
Completed
- Esophageal Carcinoma
- Tetrathiomolybdate (TM)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Jul 12, 2016
Diffusion-weighted Magnetic Resonance Imagingfor Early Response
Unknown status
- Esophageal Carcinoma
- DW-MRI
-
Changsha, Hunan, ChinaHunan province tumor pospital
Aug 15, 2016
Esophageal Carcinoma Trial in Guangzhou (Liposomal Paclitaxel, Nedaplatin)
Completed
- Esophageal Carcinoma
- Liposomal Paclitaxel
- Nedaplatin
-
Guangzhou, Guangdong, ChinaMedical Oncology,Sun Yat-sen University Cancer Center
Aug 5, 2016
Esophageal Carcinoma Trial in New York (Cisplatin, Irinotecan, External Beam Radiation Therapy)
Completed
- Esophageal Carcinoma
- Cisplatin
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 18, 2015
Esophageal Carcinoma Trial (Bevacizumab, cetuximab)
Withdrawn
- Esophageal Carcinoma
- Bevacizumab, cetuximab
- (no location specified)
Nov 18, 2013
Esophageal Carcinoma Trial in Hangzhou (intensity modulated radiation therapy in both arms, concurrent chemo with radiation)
Unknown status
- Esophageal Carcinoma
- intensity modulated radiation therapy in both arms
- concurrent chemotherapy with radiation
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 3, 2013
Esophageal Carcinoma Trial in Taian (lobaplatin , 5-FU ,leucovorin)
Unknown status
- Esophageal Carcinoma
- lobaplatin , 5-FU ,leucovorin
-
Taian, Shandong, ChinaTaian Cancer Hospital
Jan 4, 2010
Esophageal Carcinoma Trial in Beijing, Guangzhou, Shanghai (, Sodium Glycididazole)
Unknown status
- Esophageal Carcinoma
- placebo
- Sodium Glycididazole
-
Beijing, Beijing, China
- +3 more
May 13, 2008